Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy, Active”

218 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 218 results

Early research (Phase 1)Study completedNCT00779883
What this trial is testing

A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)

Who this might be right for
Chronic Lymphocytic Leukemia
Memgen, LLC 9
Testing effectiveness (Phase 2)UnknownNCT03579654
What this trial is testing

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076
What this trial is testing

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

Who this might be right for
Endometrial CarcinomaCervix Carcinoma
NETRIS Pharma 240
Testing effectiveness (Phase 2)Study completedNCT00016133
What this trial is testing

Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

Who this might be right for
Colorectal Cancer
Intracel
Testing effectiveness (Phase 2)Study completedNCT03008304
What this trial is testing

High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 20
Early research (Phase 1)UnknownNCT03599375
What this trial is testing

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, B-Cell
jiuwei cui 20
Not applicableTemporarily pausedNCT04470999
What this trial is testing

Changes in Cellular Immune Profile During COVID-19 Infection

Who this might be right for
Covid19SARS-CoV-2
Serhat Gumrukcu, MD PhD 25
Large-scale testing (Phase 3)Looking for participantsNCT06441110
What this trial is testing

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsBCG VaccineImmunotherapy, Active+3 more
Fujian Medical University Union Hospital 76
Testing effectiveness (Phase 2)Study completedNCT00431561
What this trial is testing

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Isarna Therapeutics GmbH 141
Testing effectiveness (Phase 2)Ended earlyNCT03875495
What this trial is testing

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Who this might be right for
Multiple Myeloma
Genenta Science 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04999969
What this trial is testing

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
AstraZeneca 126
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Testing effectiveness (Phase 2)Temporarily pausedNCT05642195
What this trial is testing

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNon-Small Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung+1 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00849875
What this trial is testing

Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
GlaxoSmithKline 48
Testing effectiveness (Phase 2)Looking for participantsNCT04143711
What this trial is testing

Study of DF1001 in Patients with Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 378
Testing effectiveness (Phase 2)Study completedNCT00003433
What this trial is testing

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Duke Cancer Institute
Early research (Phase 1)Study completedNCT02310464
What this trial is testing

Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects

Who this might be right for
Metastatic Gastric CancerMetastatic Breast CancerMetastatic Colorectal Cancer+1 more
OBI Pharma, Inc 25
Testing effectiveness (Phase 2)Study completedNCT02137746
What this trial is testing

Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 24
Early research (Phase 1)Ended earlyNCT00010127
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 3
Load More Results